Adolescent vaccine co-administration and coverage in New York City: 2007-2013

Pediatrics

Volumn 134, Issue 6, 2014, Pages e1576-e1583

  Sull, Monica ^a   Eavey, Joanna ^a,b   Papadouka, Vikki ^a   Mandell, Rebecca ^a,b   Hansen, Michael A ^a,c   Zucker, Jane R ^a,d  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Atlantic Management Center Inc ^*  (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Adolescent immunization; Co administration; HPV vaccine; MCV4; Tdap

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCUS VACCINE; WART VIRUS VACCINE; SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE; VACCINE;

ADOLESCENT; AGE; ARTICLE; CHILD; DIPHTHERIA; DRUG UPTAKE; EPIDEMIOLOGICAL DATA; FEMALE; GENDER; HUMAN; MALE; MENINGOCOCCOSIS; MULTIPLE CYCLE TREATMENT; PAPILLOMAVIRUS INFECTION; PERTUSSIS; SCHOOL CHILD; TETANUS; UNITED STATES; VACCINATION; VACCINATION COVERAGE; COHORT ANALYSIS; IMMUNIZATION; MASS IMMUNIZATION; TRENDS; URBAN POPULATION;

ADOLESCENT; COHORT STUDIES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; MASS VACCINATION; MENINGOCOCCAL VACCINES; NEW YORK CITY; PAPILLOMAVIRUS VACCINES; URBAN POPULATION; VACCINES, COMBINED;

EID: 84913589259     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1452     Document Type: Article

References (39)

1. Immunization of Adolescents Recommendations of the Advisory Committee on Immunization Practices. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Recomm Rep. 1996;45(RR-13):1-16
2. Broder KR, Cortese MM, Iskander JK, et al; Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-3):1-34
3. Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR-7):1-21
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24
5. Centers for Disease Control and Prevention (CDC). National vaccination coverage among adolescents aged 13-17 years - United States, 2006. MMWR Morb Mortal Wkly Rep. 2007;56 (34):885-888
6. Centers for Disease Control and Prevention (CDC). CDC Preteen and Teen Vaccine Communication Campaign. Updated May 20, 2011. Available at: www.cdc.gov/vaccines/who/ teens/campaigns.html. Accessed December 25, 2013
7. Orenstein WA, Hinman AR. The immunization system in the United States: the role of school immunization laws. Vaccine. 1999; 17(Suppl 3):S19-S24
8. Olshen E, Mahon BE, Wang S, Woods ER. The impact of state policies on vaccine coverage by age 13 in an insured population. J Adolesc Health. 2007;40(5):405-411
9. Wilson TR, Fishbein DB, Ellis PA, Edlavitch SA. The impact of a school entry law on adolescent immunization rates. J Adolesc Health. 2005;37(6):511-516
10. Centers for Disease Control and Prevention (CDC). Effectiveness of a middle school vaccination law-California, 1999-2001. MMWR Morb Mortal Wkly Rep. 2001;50(31):660-663
11. New York State Department of Health. Sixth grade entry law for Tdap immunizations. School administrator letter. March 2007. Available at: www.health.ny.gov/prevention/ immunization/schools/sixth-grade-entry-law- for-tdap.htm. Accessed November 7, 2013
12. Public Health Law 2164.2.b. New York State Legislature. Available at: http://public.leginfo.state.ny.us/LAWSSEAF.cgi?QUERYTYPE= L AWS+&QUE RY D ATA=$ $ PBH 21 6 4 $ $@TXPBH02164+&LIST=LAW+&BROWSER= EXPLORER+&TOKEN=59252407+&TARGET= VIEW. Accessed May 14, 2010
13. New York City Department of Health and Mental Hygiene. Immunization information system annual report 2013. Submitted to Program Operations Branch, Immunization Services Division, Centers for Disease Control and Prevention March 31, 2014
14. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20): 626-629
15. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705-1708
16. Cullen KA, Stokley S, Markowitz LE. Uptake of human papillomavirus vaccine among adolescent males and females: immunization information system sentinel sites, 2009-2012. Acad Pediatr. 2014;14(5):497-504
17. Lopez AS, Cardemil C, Pabst LJ, Cullen KA, Leung J, Bialek SR; Division of Viral Diseases; Centers for Disease Control and Prevention (CDC). Two-dose varicella vaccination coverage among children aged 7 years - six sentinel sites, United States, 2006-2012. MMWR Morb Mortal Wkly Rep. 2014;63(8):174-177
18. Pabst LJ, Papadouka V, Cullen KA, Bartlett DL. Methodological considerations: denominators for immunization information system- based vaccine coverage assessments. Paper presented at 43rd National Immunization Conference; April 1, 2009; Dallas, TX
19. Jacobs RJ, Meyerhoff AS. Effect of middle school entry requirements on hepatitis B vaccination coverage. J Adolesc Health. 2004; 34(5):420-423
20. Kharbanda EO, Stockwell MS, Colgrove J, Natarajan K, Rickert VI. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Am J Public Health. 2010;100(9):1635-1640
21. Stokley S, Jeyarajah J, Yankey D, et al; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination coverage among adolescents, 2007- 2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morb Mortal Wkly Rep. 2014;63(29):620-624
22. Centers for Disease Control and Prevention (CDC). Q&A about IIS Sentinel Sites. Updated February 25, 2014. Available at: www. cdc.gov/vaccines/programs/iis/activities/ sentinel-sites.html. Accessed May 12, 2014
23. Lee GM, Lorick SA, Pfoh E, Kleinman K, Fishbein D. Adolescent immunizations: missed opportunities for prevention. Pediatrics. 2008; 122(4):711-717
24. Wong CA, Taylor JA, Wright JA, Opel DJ, Katzenellenbogen RA. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health. 2013;53(4):492-497
25. Elam-Evans LD, Yankey D, Jeyarajah J, et al; Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC). National, regional, state, and selected local area vaccination coverage among adolescents aged 13 - 17 years - United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(29):625-633
26. Eagle DB, Zucker JR. Provider attitudes towards human papillomavirus vaccine. Poster presented at 42nd National Immunization Conference; March 2008; Atlanta, GA
27. Labadie J. Postlicensure safety evaluation of human papilloma virus vaccines. Int J Risk Saf Med. 2011;23(2):103-112
28. Garland SM, Hernandez-Avila M, Wheeler CM, et al; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356(19):1928-1943
29. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915-1927
30. Darden PM, Thompson DM, Roberts JR, et al. Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010. Pediatrics. 2013;131(4):645-651
31. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76-82
32. Reynolds D, O'Connell KA. Testing a model for parental acceptance of human papillomavirus vaccine in 9- to 18-year-old girls: a theory-guided study. J Pediatr Nurs. 2012;27(6):614-625
33. Stokley S, Cohn A, Dorell C, et al. Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics. 2011;128(6): 1078-1086
34. Dorell C, Yankey D, Kennedy A, Stokley S. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey-Teen, 2010. Clin Pediatr (Phila). 2013;52(2):162-170
35. Joseph NP, Clark JA, Bauchner H, et al. Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women. Womens Health Issues. 2012;22(6):e571-e579
36. Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126(3):425-433
37. Finer LB, Philbin JM. Sexual initiation, contraceptive use, and pregnancy among young adolescents. Pediatrics. 2013;131(5):886-891
38. Eaton DK, Kann L, Kinchen S, et al; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance: United States, 2009. MMWR Surveill Summ. 2010; 59(5):1-142
39. Centers for Disease Control and Prevention. Incidence, prevalence, and cost of sexually transmitted infections in the United States. 2013. Available at: www.cdc.gov/std/stats/ STI-Estimates-Fact-Sheet-Feb-2013.pdf. Accessed April 17, 2014